傑瑞股份(002353.SZ):3名股東合計減持89.48萬股
格隆匯10月31日丨傑瑞股份(002353.SZ)公佈,公司於2019年10月31日收到公司控股股東孫偉傑、王坤曉、劉貞峯(三人為一致行動人)出具的《簡式權益變動報告書》。孫偉傑、王坤曉、劉貞峯於2019年10月30日-10月31日通過大宗交易方式減持股份合計約89.48萬股,三人通過證券交易所的證券交易,擁有權益的股份佔公司已發行股份的比例累計減少5%。
此次減持後,孫偉傑、王坤曉、劉貞峯合計持股比例由50.05%降至49.95%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.